Cited by 176Cutaneous Melanoma Detection and ManagementGlobal Cancer Incidence and ScreeningHealth disparities and outcomes

Survival for Patients With Invasive Cutaneous Melanoma Among Ethnic Groups: The Effects of Socioeconomic Status and Treatment

Open access
Zell, Jason A., Cinar, Pelin, Mobasher, Mehrdad, Ziogas, Argyrios, Meyskens, Frank L., Anton-Culver, Hoda·2008·Journal of Clinical Oncology

Abstract

Purpose: Although uncommon, melanoma is associated with poor survival characteristics among African Americans and Hispanics compared with non-Hispanic whites (NHWs). Low socioeconomic status (SES) is also associated with poor survival among patients with melanoma, but it is not known whether this is because of SES itself or because of treatment disparities. We set out to determine this by using the large, population-based California Cancer Registry (CCR) database as a model. Patients and Methods: We conducted a case-only analysis of CCR data (1993 to 2003), including a descriptive analysis of relevant clinical variables and SES. The SES variable used has been derived from principle component analysis of census block-level CCR data that was linked to census data to address seven indicators of SES. Univariate analyses of overall survival (OS) were conducted using the Kaplan-Meier method. Multivariate survival analyses were performed using Cox proportional hazard ratios (HRs). Results: A total of 39,049 incident patient cases of cutaneous melanoma, including 36,694 in NHWs; 127 in African Americans; 1,996 in Hispanics; and 262 in Asian-Americans, were analyzed. Higher SES was associated with an early stage at presentation (P < .0001), with treatment with surgery (P = .0005), and with prolonged survival (P < .0001). After adjustments for age, sex, histology, American Joint Committee on Cancer stage, anatomic site, treatment, and SES, a statistically significant increased risk of death was observed for African Americans compared with NHWs (HR, 1.60; 95% CI, 1.17 to 2.18); no survival differences were noted for Asians or Hispanics compared with NHWs in the adjusted analysis. Conclusion: Low SES independently predicts poor outcome among patients with cutaneous melanoma. However, the poor OS observed for African American patients with melanoma is not explained by differences in treatment or SES.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2007.12.3604

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • While individuals with SOC have lower melanoma incidence, their mortality rates are disproportionately higher than White individuals.

    “While individuals with SOC have a lower incidence of melanoma, their mortality rates are disproportionately higher than those of White individuals [70–74].”

    From Photoprotection for skin of color (2022) · cites this paper as [73]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zell, J. A., Cinar, P., Mobasher, M., Ziogas, A., Meyskens, F. L., & Anton-Culver, H.
Affiliations
  • University of California, Irvine (US)
  • From the Division of Hematology/Oncology, Department of Internal Medicine, Chao Family Comprehensive Cancer Center; the Department of Epidemiology, School of Medicine; and the Genetic Epidemiology Research Institute, University of California, Irvine; and the Divisions of Hematology and Oncology, Stanford University, Palo Alto, CA
Venue
Journal of Clinical Oncology
Published
2008-01-01
Volume
26
Issue
1
Pages
66-75
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2118033225
Cited by
176
References
42
Citations by year
2026: 4 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 16 · 2021: 9 · 2020: 5 · 2019: 3 · 2018: 8 · 2017: 12 · 2016: 9 · 2015: 10 · 2014: 10 · 2013: 6 · 2012: 10
FWCI
5.38
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Cancer Institute (P30CA062203)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Health › Health disparities and outcomes
Keywords
cutaneous melanoma, socioeconomic status, racial disparities, African Americans, Hispanic patients, Asian Americans, overall survival, treatment disparities, early-stage melanoma, surgical treatment, California Cancer Registry
MeSH terms
Aged, Aged, 80 and over, California, Ethnicity, Female, Humans, Male, Melanoma, Neoplasm Invasiveness, Neoplasm Staging, Retrospective Studies, Skin Neoplasms, Social Class, Socioeconomic Factors, United States, Cohort Studies, Survival Rate, SEER Program

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review